دورية أكاديمية
أعرض في EDS

The Impact of Nano-Hydroxyapatite Scaffold Enrichment on Bone Regeneration In Vivo-A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: The Impact of Nano-Hydroxyapatite Scaffold Enrichment on Bone Regeneration In Vivo-A Systematic Review.
المؤلفون: Mitić D; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Čarkić J; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Jaćimović J; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Lazarević M; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Jakšić Karišik M; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Toljić B; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia., Milašin J; School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia.
المصدر: Biomimetics (Basel, Switzerland) [Biomimetics (Basel)] 2024 Jun 25; Vol. 9 (7). Date of Electronic Publication: 2024 Jun 25.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101719189 Publication Model: Electronic Cited Medium: Internet ISSN: 2313-7673 (Electronic) Linking ISSN: 23137673 NLM ISO Abbreviation: Biomimetics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2016]-
مستخلص: Objectives: In order to ensure improved and accelerated bone regeneration, nano-hydroxyapatite scaffolds are often enriched with different bioactive components to further accelerate and improve bone healing. In this review, we critically examined whether the enrichment of nHAp/polymer scaffolds with growth factors, hormones, polypeptides, microRNAs and exosomes improved new bone formation in vivo.
Materials and Methods: Out of 2989 articles obtained from the literature search, 106 papers were read in full, and only 12 articles met the inclusion criteria for this review.
Results: Several bioactive components were reported to stimulate accelerated bone regeneration in a variety of bone defect models, showing better results than bone grafting with nHAp scaffolds alone.
Conclusions: The results indicated that composite materials based on nHAp are excellent candidates as bone substitutes, while nHAp scaffold enrichment further accelerates bone regeneration. The standardization of animal models should be provided in order to clearly define the most significant parameters of in vivo studies. Only in this way can the adequate comparison of findings from different in vivo studies be possible, further advancing our knowledge on bone regeneration and enabling its translation to clinical settings.
References: J Biomed Mater Res B Appl Biomater. 2023 Jan;111(1):203-219. (PMID: 35906778)
Biomed Mater. 2008 Dec;3(4):044111. (PMID: 19029602)
J Clin Epidemiol. 2016 Jul;75:40-6. (PMID: 27005575)
J Orthop Trauma. 2018 Mar;32 Suppl 1:S7-S11. (PMID: 29461395)
Ann Biomed Eng. 2021 Sep;49(9):2114-2125. (PMID: 33560466)
Pharmaceutics. 2023 Jan 19;15(2):. (PMID: 36839667)
Gene Ther. 2006 Jul;13(14):1061-7. (PMID: 16819538)
Front Bioeng Biotechnol. 2022 Mar 31;10:810880. (PMID: 35433652)
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5186-5204. (PMID: 37585807)
Bone. 2011 Feb;48(2):321-31. (PMID: 20932949)
Biomaterials. 2009 May;30(13):2479-88. (PMID: 19162318)
Nanomaterials (Basel). 2021 Sep 29;11(10):. (PMID: 34685010)
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5222-5254. (PMID: 37585562)
Biomaterials. 2023 Dec;303:122398. (PMID: 37979514)
Nanomaterials (Basel). 2020 May 09;10(5):. (PMID: 32397466)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Macromol Biosci. 2020 Dec;20(12):e2000228. (PMID: 32830435)
Laryngoscope. 2010 May;120(5):895-901. (PMID: 20422682)
Biomaterials. 2009 Oct;30(31):6276-85. (PMID: 19683811)
J Pharm Bioallied Sci. 2021 Jun;13(Suppl 1):S11-S14. (PMID: 34447034)
Acta Biomater. 2023 Dec;172:480-493. (PMID: 37797708)
J Tissue Eng Regen Med. 2018 Apr;12(4):864-877. (PMID: 27885807)
Acta Biomater. 2020 Oct 15;116:186-200. (PMID: 32911108)
Growth Factors. 2014 Feb;32(1):41-52. (PMID: 24438070)
Biomed Pharmacother. 2020 Oct;130:110516. (PMID: 32674018)
Bone. 2012 Feb;50(2):452-6. (PMID: 21723973)
Colloids Surf B Biointerfaces. 2020 Feb;186:110719. (PMID: 31846893)
Eur Cell Mater. 2016 May 24;31:312-22. (PMID: 27215739)
J Biomed Mater Res A. 2006 Jun 15;77(4):700-6. (PMID: 16550532)
J Colloid Interface Sci. 2020 Jul 1;571:326-336. (PMID: 32208203)
Materials (Basel). 2023 Feb 03;16(3):. (PMID: 36770309)
AAPS J. 2017 May;19(3):703-711. (PMID: 28138909)
Sci Rep. 2021 Jan 12;11(1):746. (PMID: 33436904)
Acta Biomater. 2020 Jun;109:267-279. (PMID: 32251781)
Polymers (Basel). 2022 Aug 08;14(15):. (PMID: 35956735)
J Orthop Trauma. 2019 Apr;33(4):203-213. (PMID: 30633080)
J Orthop Res. 2011 Nov;29(11):1745-52. (PMID: 21500252)
J Clin Med. 2023 Jun 15;12(12):. (PMID: 37373757)
J Control Release. 2016 Feb 10;223:126-136. (PMID: 26721447)
Int J Mol Sci. 2021 Jan 12;22(2):. (PMID: 33445616)
Biomed Mater Eng. 2016 Nov 25;27(5):495-505. (PMID: 27885997)
Oral Maxillofac Surg. 2017 Jun;21(2):109-129. (PMID: 28194530)
Calcif Tissue Int. 1996 Dec;59(6):492-5. (PMID: 8939777)
Materials (Basel). 2020 Mar 25;13(7):. (PMID: 32218290)
Bone. 1998 Sep;23(3):181-6. (PMID: 9737339)
Gen Comp Endocrinol. 2005 May 15;142(1-2):44-52. (PMID: 15862547)
Biomed Tech (Berl). 2020 Aug 27;65(4):491-505. (PMID: 32335536)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
Int J Nanomedicine. 2017 Dec 21;13:117-127. (PMID: 29317820)
BMC Med Res Methodol. 2014 Mar 26;14:43. (PMID: 24667063)
Regen Ther. 2023 Mar 30;23:25-36. (PMID: 37063095)
Int J Nanomedicine. 2022 May 02;17:1903-1925. (PMID: 35530974)
J Clin Periodontol. 2019 Jun;46 Suppl 21:124-161. (PMID: 30623464)
ACS Biomater Sci Eng. 2017 Jun 12;3(6):1092-1099. (PMID: 33429583)
Biomaterials. 2017 Apr;122:91-104. (PMID: 28110173)
Int J Biol Macromol. 2021 Aug 1;184:29-41. (PMID: 34048836)
Stem Cell Res Ther. 2023 May 15;14(1):132. (PMID: 37189187)
Biomed Mater. 2006 Jun;1(2):56-62. (PMID: 18460757)
Front Bioeng Biotechnol. 2021 Dec 15;9:773636. (PMID: 34976971)
PLoS Biol. 2020 Jul 14;18(7):e3000410. (PMID: 32663219)
Tissue Cell. 2023 Feb;80:102007. (PMID: 36577349)
Part Part Syst Charact. 2020 Oct;37(10):. (PMID: 33384477)
Int J Mol Sci. 2023 Jan 09;24(2):. (PMID: 36674810)
Langmuir. 2016 May 17;32(19):5019-28. (PMID: 27118187)
J Mater Chem B. 2021 Sep 14;9(34):6856-6869. (PMID: 34396378)
J Cell Biochem. 2019 Aug;120(8):14136-14155. (PMID: 31069839)
Tissue Eng Regen Med. 2019 Jan 5;16(2):177-189. (PMID: 30989044)
Syst Rev. 2021 Jan 26;10(1):39. (PMID: 33499930)
Bone. 2024 Jun;183:117075. (PMID: 38508371)
Cell. 2010 Jul 23;142(2):296-308. (PMID: 20655470)
Ann Anat. 2017 Sep;213:83-90. (PMID: 28655570)
فهرسة مساهمة: Keywords: bioactive components; bone scaffold; nano-hydroxyapatite; regeneration; tissue engineering
تواريخ الأحداث: Date Created: 20240726 Latest Revision: 20240728
رمز التحديث: 20240728
مُعرف محوري في PubMed: PMC11274561
DOI: 10.3390/biomimetics9070386
PMID: 39056827
قاعدة البيانات: MEDLINE
الوصف
تدمد:2313-7673
DOI:10.3390/biomimetics9070386